Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small molecule drugs. Ablynx is dedicated to creating new medicines which will make a real difference to society. Today, the Company has more than proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, oncology and respiratory disease. The Company has collaborations with multiple pharmaceutical companies including AbbVie, Boehringer Ingelheim, Eddingpharm, Merck amp Co, Merck Serono and Novartis. The Company is headquartered in Ghent, Belgium. More information can be found on www.ablynx.com.
Quote | Ablynx NV - Ordinary Shares (OTCMKTS:ABLYF)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $50.63 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Ablynx NV - Ordinary Shares (OTCMKTS:ABLYF)
Karyopharm (KPTI) slumped 17% in the pre-market yesterday, ahead of data from a mid stage study of selinexor in treatment-resistant multiple myeloma. A couple of years ago, this same drug was pitted against Darzalex in the same indication and showed similar efficacy. An FDA filing was planned ...
Ablynx ( OTCPK:ABLYF ) completes enrollment of 180 infants in a Phase 2b clinical trial, RESPIRE , assessing inhaled drug candidate ALX-0171 for the treatment of respiratory syncytial virus (RSV) infection. More news on: Ablynx NV, Sanofi, Healthcare stocks news, Read more ...
Message Board Posts | Ablynx NV - Ordinary Shares (OTCMKTS:ABLYF)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest Ablynx Nv (ABLYF) Headlines What to Watch at Merck, CytRx, and Mylan This Morn | Stock_Tracker | investorshangout | 03/08/2014 9:31:57 PM |
chartguy89: ABLYF 12.75 Stock Charts $ABLYF 1 Month Chart | chartguy89 | investorshangout | 03/05/2014 10:50:32 PM |
Stock_Tracker: ABLYF Recent News What to Watch at Merck, CytRx, and Mylan This Morning Motley Fool - | Stock_Tracker | investorshangout | 03/02/2014 4:18:12 AM |
chartguy89: ABLYF Stock Charts Saturday, February 22, 2014 at 12:04:15 AM $ABLYF Last: -0.27 | chartguy89 | investorshangout | 02/22/2014 5:04:27 AM |
chartguy89: ABLYF Stock Chart 10.65 Saturday, February 8, 2014 00:15:34 AM | chartguy89 | investorshangout | 02/08/2014 5:15:40 AM |